Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Enhancing the Bioavailability of Insoluble Drug Compounds

Despite efforts to either chemically modify discovery compounds, or to simply discount those that present difficulties, the putative efficacy of compounds which otherwise have very high affinities for the target is too compelling to ignore particularly when insoluble compounds make up close to half of the leads generated.

Stephen Perrett and Gopi Venkatesh, Eurand (April 2006)

Keywords: modify discovery compounds putative efficacy affinities insoluble

    View full article    |    Back to Ingredients, Formulations and Finishing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |